Invention Grant
US07795273B2 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
失效
吡唑并[1,5-a]吡啶-3-羧酸，为EphB和VEGFR2激酶抑制剂
![Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors](/docs/US/2010-09-14/US07795273B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
- Patent Title (中): 吡唑并[1,5-a]吡啶-3-羧酸，为EphB和VEGFR2激酶抑制剂
-
Application No.: US12096260Application Date: 2006-12-06
-
Publication No.: US07795273B2Publication Date: 2010-09-14
- Inventor: Patricia Imbach , Philipp Holzer , Pascal Furet
- Applicant: Patricia Imbach , Philipp Holzer , Pascal Furet
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Priority: GB0525065.9 20051208; GB0600931.0 20060117
- International Application: PCT/EP2006/011722 WO 20061206
- International Announcement: WO2007/065664 WO 20070614
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D491/02 ; C07D498/02
![Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors](/abs-image/US/2010/09/14/US07795273B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to novel pyrazolo[1,5-a]pyridine-3-carboxylic acid compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
Public/Granted literature
- US20080300245A1 Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acids as Ephb and Vegfr2 Kinase Inhibitors Public/Granted day:2008-12-04
Information query
IPC分类:
